Skip to main content
NCBI home page
Clinical Microbiology Reviews logoLink to Clinical Microbiology Reviews
. 1989 Jul;2(3):227–240. doi: 10.1128/cmr.2.3.227

Rocky Mountain spotted fever: a disease in need of microbiological concern.

D H Walker 1
PMCID: PMC358117  PMID: 2504480

Abstract

Rocky Mountain spotted fever, a life-threatening tick-transmitted infection, is the most prevalent rickettsiosis in the United States. This zoonosis is firmly entrenched in the tick host, which maintains the rickettsiae in nature by transovarian transmission. Although the incidence of disease fluctuates in various regions and nationwide, the problems of a deceptively difficult clinical diagnosis and little microbiologic diagnostic effort persist. Many empiric antibiotic regimens lack antirickettsial activity. There is neither an effective vaccine nor a generally available assay that is diagnostic during the early stages of illness, when treatment is most effective. Microbiology laboratories that offer only the archaic retrospective Weil-Felix serologic tests should review the needs of their patients. Research microbiologists who tackle these challenging organisms have an array of questions to address regarding rickettsial surface composition, structure-function analysis, and pathogenic and immune mechanisms, as well as laboratory diagnosis.

Full text

PDF
227

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams J. S., Walker D. H. The liver in Rocky Mountain spotted fever. Am J Clin Pathol. 1981 Feb;75(2):156–161. doi: 10.1093/ajcp/75.2.156. [DOI] [PubMed] [Google Scholar]
  2. Anacker R. L., List R. H., Mann R. E., Hayes S. F., Thomas L. A. Characterization of monoclonal antibodies protecting mice against Rickettsia rickettsii. J Infect Dis. 1985 Jun;151(6):1052–1060. doi: 10.1093/infdis/151.6.1052. [DOI] [PubMed] [Google Scholar]
  3. Anacker R. L., List R. H., Mann R. E., Wiedbrauk D. L. Antigenic heterogeneity in high- and low-virulence strains of Rickettsia rickettsii revealed by monoclonal antibodies. Infect Immun. 1986 Feb;51(2):653–660. doi: 10.1128/iai.51.2.653-660.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Anacker R. L., Mann R. E., Gonzales C. Reactivity of monoclonal antibodies to Rickettsia rickettsii with spotted fever and typhus group rickettsiae. J Clin Microbiol. 1987 Jan;25(1):167–171. doi: 10.1128/jcm.25.1.167-171.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Anacker R. L., McDonald G. A., List R. H., Mann R. E. Neutralizing activity of monoclonal antibodies to heat-sensitive and heat-resistant epitopes of Rickettsia rickettsii surface proteins. Infect Immun. 1987 Mar;55(3):825–827. doi: 10.1128/iai.55.3.825-827.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Anacker R. L., Philip R. N., Thomas L. A., Casper E. A. Indirect hemagglutination test for detection of antibody to Rickettsia rickettsii in sera from humans and common laboratory animals. J Clin Microbiol. 1979 Nov;10(5):677–684. doi: 10.1128/jcm.10.5.677-684.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Anacker R. L., Philip R. N., Williams J. C., List R. H., Mann R. E. Biochemical and immunochemical analysis of Rickettsia rickettsii strains of various degrees of virulence. Infect Immun. 1984 Jun;44(3):559–564. doi: 10.1128/iai.44.3.559-564.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Anderson B. E., Regnery R. L., Carlone G. M., Tzianabos T., McDade J. E., Fu Z. Y., Bellini W. J. Sequence analysis of the 17-kilodalton-antigen gene from Rickettsia rickettsii. J Bacteriol. 1987 Jun;169(6):2385–2390. doi: 10.1128/jb.169.6.2385-2390.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Austin F. E., Turco J., Winkler H. H. Rickettsia prowazekii requires host cell serine and glycine for growth. Infect Immun. 1987 Jan;55(1):240–244. doi: 10.1128/iai.55.1.240-244.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. BELL E. J., KOHLS G. M., STOENNER H. G., LACKMAN D. B. NONPATHOGENIC RICKETTSIAS RELATED TO THE SPOTTED FEVER GROUP ISOLATED FROM TICKS, DERMACENTOR VARIABILIS AND DERMACENTOR ANDERSONI FROM EASTERN MONTANA. J Immunol. 1963 May;90:770–781. [PubMed] [Google Scholar]
  11. BELL E. J., PICKENS E. G. A toxic substance associated with the rickettsias of the spotted fever group. J Immunol. 1953 May;70(5):461–472. [PubMed] [Google Scholar]
  12. BOVARNICK M. R., MILLER J. C. Oxidation and transamination of glutamate by typhus rickettsiae. J Biol Chem. 1950 Jun;184(2):661–676. [PubMed] [Google Scholar]
  13. BOVARNICK M. R. Phosphorylation accompanying the oxidation of glutamate by the Madrid E strain of typhus rickettsiae. J Biol Chem. 1956 May;220(1):353–361. [PubMed] [Google Scholar]
  14. BOVARNICK M. R., SCHNEIDER L. The incorporation of glycine-1-C14 by typhus rickettsiae. J Biol Chem. 1960 Jun;235:1727–1731. [PubMed] [Google Scholar]
  15. BOVARNICK M. R., SCHNEIDER L., WALTER H. The incorporation of labeled methionine by typhus rickettsiae. Biochim Biophys Acta. 1959 Jun;33(2):414–422. doi: 10.1016/0006-3002(59)90131-3. [DOI] [PubMed] [Google Scholar]
  16. BURGDORFER W., NEWHOUSE V. F., PICKENS E. G., LACKMAN D. B. Ecology of rocky mountain spotted fever in Western Montana. I. Isolation of Rickettsia rickettsii from wild mammals. Am J Hyg. 1962 Nov;76:293–301. doi: 10.1093/oxfordjournals.aje.a120284. [DOI] [PubMed] [Google Scholar]
  17. Bell W. E., Lascari A. D. Rocky mountain spotted fever. Neurological symptoms in the acute phase. Neurology. 1970 Sep;20(9):841–847. doi: 10.1212/wnl.20.9.841. [DOI] [PubMed] [Google Scholar]
  18. Bradford W. D., Croker B. P., Tisher C. C. Kidney lesions in Rocky Mountain spotted fever: a light-, immunofluorescence-, and electron-microscopic study. Am J Pathol. 1979 Nov;97(2):381–392. [PMC free article] [PubMed] [Google Scholar]
  19. Burgdorfer W., Brinton L. P. Mechanisms of transovarial infection of spotted fever Rickettsiae in ticks. Ann N Y Acad Sci. 1975;266:61–72. doi: 10.1111/j.1749-6632.1975.tb35088.x. [DOI] [PubMed] [Google Scholar]
  20. Burgdorfer W., Cooney J. C., Mavros A. J., Jellison W. L., Maser C. The role of cottontail rabbits (Sylvilagus spp.) in the ecology of Rickettsia rickettsii in the United States. Am J Trop Med Hyg. 1980 Jul;29(4):686–690. doi: 10.4269/ajtmh.1980.29.686. [DOI] [PubMed] [Google Scholar]
  21. Burgdorfer W., Friedhoff K. T., Lancaster J. L., Jr Natural history of tick-borne spotted fever in the USA. Susceptibility of small mammals to virulent Rickettsia rickettsii. Bull World Health Organ. 1966;35(2):149–153. [PMC free article] [PubMed] [Google Scholar]
  22. Burgdorfer W., Sexton D. J., Gerloff R. K., Anacker R. L., Philip R. N., Thomas L. A. Rhipicephalus sanguineus: vector of a new spotted fever group rickettsia in the United States. Infect Immun. 1975 Jul;12(1):205–210. doi: 10.1128/iai.12.1.205-210.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Burgdorfer W. Tick-borne diseases in the United States: Rocky Mountain spotted fever and Colorado tick fever. A review. Acta Trop. 1977 Jun;34(2):103–126. [PubMed] [Google Scholar]
  24. CHANG R. S., MURRAY E. S., SNYDER J. C. Erythrocyte-sensitizing substances from Rickettsiae of the Rocky Mountain spotted fever group. J Immunol. 1954 Jul;73(1):8–15. [PubMed] [Google Scholar]
  25. COONS A. H., SNYDER J. C. Localization of antigen in tissue cells; antigens of rickettsiae and mumps virus. J Exp Med. 1950 Jan 1;91(1):31-8, pl. doi: 10.1084/jem.91.1.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Clements M. L., Dumler J. S., Fiset P., Wisseman C. L., Jr, Snyder M. J., Levine M. M. Serodiagnosis of Rocky Mountain spotted fever: comparison of IgM and IgG enzyme-linked immunosorbent assays and indirect fluorescent antibody test. J Infect Dis. 1983 Nov;148(5):876–880. doi: 10.1093/infdis/148.5.876. [DOI] [PubMed] [Google Scholar]
  27. Clements M. L., Wisseman C. L., Jr, Woodward T. E., Fiset P., Dumler J. S., McNamee W., Black R. E., Rooney J., Hughes T. P., Levine M. M. Reactogenicity, immunogenicity, and efficacy of a chick embryo cell-derived vaccine for Rocky Mountain spotted fever. J Infect Dis. 1983 Nov;148(5):922–930. doi: 10.1093/infdis/148.5.922. [DOI] [PubMed] [Google Scholar]
  28. Davis A. E., Jr, Bradford W. D. Abdominal pain resembling acute appendicitis in Rocky Mountain spotted fever. JAMA. 1982 May 28;247(20):2811–2812. [PubMed] [Google Scholar]
  29. Deep W. D., Schriever H. G., Turner W. Defibrination syndrome in Rocky Mountain spotted fever. A case report with heparin therapy. Va Med Mon (1918) 1969 Feb;96(2):92–95. [PubMed] [Google Scholar]
  30. Donohue J. F. Lower respiratory tract involvement in Rocky Mountain spotted fever. Arch Intern Med. 1980 Feb;140(2):223–227. [PubMed] [Google Scholar]
  31. DuPont H. L., Hornick R. B., Dawkins A. T., Heiner G. G., Fabrikant I. B., Wisseman C. L., Jr, Woodward T. E. Rocky Mountain spotted fever: a comparative study of the active immunity induced by inactivated and viable pathogenic Rickettsia rickettsii. J Infect Dis. 1973 Sep;128(3):340–344. doi: 10.1093/infdis/128.3.340. [DOI] [PubMed] [Google Scholar]
  32. FLECK L., PORAT S., EVENCHIK Z., KLINGBERG M. A. The renal excretion of specific microbial substances during the course of infection with murine typhus rickettsiae. Am J Hyg. 1960 Nov;72:351–361. doi: 10.1093/oxfordjournals.aje.a120158. [DOI] [PubMed] [Google Scholar]
  33. Feng H. M., Kirkman C., Walker D. H. Radioimmunoprecipitation of [35S]methionine-radiolabeled proteins of Rickettsia conorii and Rickettsia rickettsii. J Infect Dis. 1986 Oct;154(4):717–721. doi: 10.1093/infdis/154.4.717. [DOI] [PubMed] [Google Scholar]
  34. Feng H. M., Walker D. H., Wang J. G. Analysis of T-cell-dependent and -independent antigens of Rickettsia conorii with monoclonal antibodies. Infect Immun. 1987 Jan;55(1):7–15. doi: 10.1128/iai.55.1.7-15.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Feng W. C., Murray E. S., Burgdorfer W., Spielman J. M., Rosenberg G., Dang K., Smith C., Spickert C., Waner J. L. Spotted fever group rickettsiae in Dermacentor variabilis from Cape Cod, Massachusetts. Am J Trop Med Hyg. 1980 Jul;29(4):691–694. doi: 10.4269/ajtmh.1980.29.691. [DOI] [PubMed] [Google Scholar]
  36. Fiset P., Ormsbee R. A., Silberman R., Peacock M., Spielman S. H. A microagglutination technique for detection and measurement of rickettsial antibodies. Acta Virol. 1969 Jan;13(1):60–66. [PubMed] [Google Scholar]
  37. Goodwin C. S., Tyrrell D. A., Head B., Rees R. J. Inhibition of haemaggregation by lepromin and other mycobacterial substances. Nature. 1967 Dec 9;216(5119):1019–1020. doi: 10.1038/2161019a0. [DOI] [PubMed] [Google Scholar]
  38. Green W. R., Walker D. H., Cain B. G. Fatal viscerotropic Rocky Mountain spotted fever. Report of a case diagnosed by immunofluorescence. Am J Med. 1978 Mar;64(3):523–528. doi: 10.1016/0002-9343(78)90247-4. [DOI] [PubMed] [Google Scholar]
  39. HARRELL G. T. Rocky Mountain spotted fever. Medicine (Baltimore) 1949 Dec;28(4):333–370. doi: 10.1097/00005792-194912000-00001. [DOI] [PubMed] [Google Scholar]
  40. Hall W. C., Bagley L. R. Identification of Rickettsia rickettsii in formalin-fixed, paraffin-embedded tissues by immunofluorescence. J Clin Microbiol. 1978 Aug;8(2):242–245. doi: 10.1128/jcm.8.2.242-245.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Harden V. A. Koch's postulates and the etiology of rickettsial diseases. J Hist Med Allied Sci. 1987 Jul;42(3):277–295. doi: 10.1093/jhmas/42.3.277. [DOI] [PubMed] [Google Scholar]
  42. Hattwick M. A., O'Brien R. J., Hanson B. F. Rocky Mountain spotted fever: epidemiology of an increasing problem. Ann Intern Med. 1976 Jun;84(6):732–739. doi: 10.7326/0003-4819-84-6-732. [DOI] [PubMed] [Google Scholar]
  43. Hattwick M. A., Retailliau H., O'Brien R. J., Slutzker M., Fontaine R. E., Hanson B. Fatal Rocky Mountain spotted fever. JAMA. 1978 Sep 29;240(14):1499–1503. [PubMed] [Google Scholar]
  44. Hayes S. F., Burgdorfer W. Reactivation of Rickettsia rickettsii in Dermacentor andersoni ticks: an ultrastructural analysis. Infect Immun. 1982 Aug;37(2):779–785. doi: 10.1128/iai.37.2.779-785.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Haynes R. E., Sanders D. Y., Cramblett H. G. Rocky Mountain spotted fever in children. J Pediatr. 1970 May;76(5):685–693. doi: 10.1016/s0022-3476(70)80285-2. [DOI] [PubMed] [Google Scholar]
  46. Hechemy K. E., Anacker R. L., Philip R. N., Kleeman K. T., MacCormack J. N., Sasowski S. J., Michaelson E. E. Detection of Rocky Mountain spotted fever antibodies by a latex agglutination test. J Clin Microbiol. 1980 Aug;12(2):144–150. doi: 10.1128/jcm.12.2.144-150.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Hechemy K. E., Michaelson E. E., Anacker R. L., Zdeb M., Sasowski S. J., Kleeman K. T., Joseph J. M., Patel J., Kudlac J., Elliott L. B. Evaluation of latex-Rickettsia rickettsii test for Rocky Mountain spotted fever in 11 laboratories. J Clin Microbiol. 1983 Oct;18(4):938–946. doi: 10.1128/jcm.18.4.938-946.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Hechemy K. E., Stevens R. W., Sasowski S., Michaelson E. E., Casper E. A., Philip R. N. Discrepancies in Weil-Felix and microimmunofluorescence test results for Rocky Mountain spotted fever. J Clin Microbiol. 1979 Feb;9(2):292–293. doi: 10.1128/jcm.9.2.292-293.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Helmick C. G., Bernard K. W., D'Angelo L. J. Rocky Mountain spotted fever: clinical, laboratory, and epidemiological features of 262 cases. J Infect Dis. 1984 Oct;150(4):480–488. doi: 10.1093/infdis/150.4.480. [DOI] [PubMed] [Google Scholar]
  50. Horney L. F., Walker D. H. Meningoencephalitis as a major manifestation of Rocky Mountain spotted fever. South Med J. 1988 Jul;81(7):915–918. doi: 10.1097/00007611-198807000-00028. [DOI] [PubMed] [Google Scholar]
  51. Hughes L. E., Clifford C. M., Gresbrink R., Thomas L. A., Keirans J. E. Isolation of a spotted fever group rickettsia from the Pacific Coast tick, Ixodes pacificus, in Oregon. Am J Trop Med Hyg. 1976 May;25(3):513–516. doi: 10.4269/ajtmh.1976.25.513. [DOI] [PubMed] [Google Scholar]
  52. Hébert G. A., Tzianabos T., Gamble W. C., Chappell W. A. Development and characterization of high-titered, group-specific fluorescent-antibody reagents for direct identification of rickettsiae in clinical specimens. J Clin Microbiol. 1980 May;11(5):503–507. doi: 10.1128/jcm.11.5.503-507.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Jiminez J., Byrne W. J., Seibert J. J., Euler A. R. Gastrointestinal symptoms in Rocky Mountain Spotted Fever. Histopathologic finding of ulcerative enteritis with vascular. Clin Pediatr (Phila) 1982 Oct;21(10):581–584. doi: 10.1177/000992288202101001. [DOI] [PubMed] [Google Scholar]
  54. Kaplan J. E., Schonberger L. B. The sensitivity of various serologic tests in the diagnosis of Rocky Mountain spotted fever. Am J Trop Med Hyg. 1986 Jul;35(4):840–844. doi: 10.4269/ajtmh.1986.35.840. [DOI] [PubMed] [Google Scholar]
  55. Kaplowitz L. G., Lange J. V., Fischer J. J., Walker D. H. Correlation of rickettsial titers, circulating endotoxin, and clinical features in Rocky Mountain spotted fever. Arch Intern Med. 1983 Jun;143(6):1149–1151. [PubMed] [Google Scholar]
  56. Kurnick J. E., Malinow S. H., Snyderman M. C. Disseminated intravascular coagulation in Rocky Mountain spotted fever. South Med J. 1974 May;67(5):623–625. doi: 10.1097/00007611-197405000-00027. [DOI] [PubMed] [Google Scholar]
  57. Lange J. V., Walker D. H. Production and characterization of monoclonal antibodies to Rickettsia rickettsii. Infect Immun. 1984 Nov;46(2):289–294. doi: 10.1128/iai.46.2.289-294.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Lange J. V., Walker D. H., Wester T. B. Documented Rocky Mountain spotted fever in Wintertime. JAMA. 1982 May 7;247(17):2403–2404. [PubMed] [Google Scholar]
  59. Lankford H. V., Glauser F. L. Cardiopulmonary dynamics in a severe case of Rocky Mountain spotted fever. Arch Intern Med. 1980 Oct;140(10):1357–1359. [PubMed] [Google Scholar]
  60. Li H., Jerrells T. R., Spitalny G. L., Walker D. H. Gamma interferon as a crucial host defense against Rickettsia conorii in vivo. Infect Immun. 1987 May;55(5):1252–1255. doi: 10.1128/iai.55.5.1252-1255.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Li H., Lenz B., Walker D. H. Protective monoclonal antibodies recognize heat-labile epitopes on surface proteins of spotted fever group rickettsiae. Infect Immun. 1988 Oct;56(10):2587–2593. doi: 10.1128/iai.56.10.2587-2593.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Marrero M., Raoult D. Centrifugation-shell vial technique for rapid detection of Mediterranean spotted fever rickettsia in blood culture. Am J Trop Med Hyg. 1989 Feb;40(2):197–199. doi: 10.4269/ajtmh.1989.40.197. [DOI] [PubMed] [Google Scholar]
  63. Marx R. S., McCall C. E., Abramson J. S., Harlan J. E. Rocky Mountain spotted fever. Serological evidence of previous subclinical infection in children. Am J Dis Child. 1982 Jan;136(1):16–18. [PubMed] [Google Scholar]
  64. McDade J. E., Newhouse V. F. Natural history of Rickettsia rickettsii. Annu Rev Microbiol. 1986;40:287–309. doi: 10.1146/annurev.mi.40.100186.001443. [DOI] [PubMed] [Google Scholar]
  65. McDade J. E., Shepard C. C., Fraser D. W., Tsai T. R., Redus M. A., Dowdle W. R. Legionnaires' disease: isolation of a bacterium and demonstration of its role in other respiratory disease. N Engl J Med. 1977 Dec 1;297(22):1197–1203. doi: 10.1056/NEJM197712012972202. [DOI] [PubMed] [Google Scholar]
  66. McDonald G. A., Anacker R. L., Garjian K. Cloned gene of Rickettsia rickettsii surface antigen: candidate vaccine for Rocky Mountain spotted fever. Science. 1987 Jan 2;235(4784):83–85. doi: 10.1126/science.3099387. [DOI] [PubMed] [Google Scholar]
  67. McDonald G. A., Anacker R. L., Mann R. E., Milch L. J. Protection of guinea pigs from experimental Rocky Mountain spotted fever with a cloned antigen of Rickettsia rickettsii. J Infect Dis. 1988 Jul;158(1):228–231. doi: 10.1093/infdis/158.1.228. [DOI] [PubMed] [Google Scholar]
  68. Middleton D. B. Rocky Mountain spotted fever: gastrointestinal and laboratory manifestations. South Med J. 1978 Jun;71(6):629–632. doi: 10.1097/00007611-197806000-00007. [DOI] [PubMed] [Google Scholar]
  69. Miller J. Q., Price T. R. The nervous system in Rocky Mountain spotted fever. Neurology. 1972 Jun;22(6):561–566. doi: 10.1212/wnl.22.6.561. [DOI] [PubMed] [Google Scholar]
  70. Newhouse V. F., Shepard C. C., Redus M. D., Tzianabos T., McDade J. E. A comparison of the complement fixation, indirect fluorescent antibody, and microagglutination tests for the serological diagnosis of rickettsial diseases. Am J Trop Med Hyg. 1979 Mar;28(2):387–395. doi: 10.4269/ajtmh.1979.28.387. [DOI] [PubMed] [Google Scholar]
  71. Norment B. R., Burgdorfer W. Susceptibility and reservoir potential of the dog to spotted fever-group rickettsiae. Am J Vet Res. 1984 Sep;45(9):1706–1710. [PubMed] [Google Scholar]
  72. PARKER R. R., PICKENS E. G., LACKMAN D. B., BELLE E. J., THRAIKILL F. B. Isolation and characterization of Rocky Mountain Spotted Fever Rickettsiae from the rabbit tick Haemaphysalis leporis-palustris Packard. Public Health Rep. 1951 Apr 13;66(15):455–463. [PMC free article] [PubMed] [Google Scholar]
  73. PRICE W. H. The epidemiology of Rocky Mountain spotted fever. I. The characterization of strain virulence of Rickettsia rickettsii. Am J Hyg. 1953 Sep;58(2):248–268. doi: 10.1093/oxfordjournals.aje.a119604. [DOI] [PubMed] [Google Scholar]
  74. Pedersen C. E., Jr, Walters V. D. Comparative electrophoresis of spotted fever group rickettsial proteins. Life Sci. 1978 Feb;22(7):583–587. doi: 10.1016/0024-3205(78)90337-5. [DOI] [PubMed] [Google Scholar]
  75. Philip R. N., Casper E. A., Burgdorfer W., Gerloff R. K., Hughes L. E., Bell E. J. Serologic typing of rickettsiae of the spotted fever group by microimmunofluorescence. J Immunol. 1978 Nov;121(5):1961–1968. [PubMed] [Google Scholar]
  76. Philip R. N., Casper E. A., MacCormack J. N., Sexton D., Thomas L. A., Anacker R. L., Burgdorfer W., Vick S. A comparison of serologic methods for diagnosis of Rocky Mountain spotted fever. Am J Epidemiol. 1977 Jan;105(1):56–67. doi: 10.1093/oxfordjournals.aje.a112356. [DOI] [PubMed] [Google Scholar]
  77. Philip R. N., Casper E. A., Ormsbee R. A., Peacock M. G., Burgdorfer W. Microimmunofluorescence test for the serological study of rocky mountain spotted fever and typhus. J Clin Microbiol. 1976 Jan;3(1):51–61. doi: 10.1128/jcm.3.1.51-61.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Philip R. N., Casper E. A. Serotypes of spotted fever group rickettsiae isolated from Dermacentor andersoni (Stiles) ticks in western Montana. Am J Trop Med Hyg. 1981 Jan;30(1):230–238. doi: 10.4269/ajtmh.1981.30.230. [DOI] [PubMed] [Google Scholar]
  79. Pike R. M. Laboratory-associated infections: summary and analysis of 3921 cases. Health Lab Sci. 1976 Apr;13(2):105–114. [PubMed] [Google Scholar]
  80. Popov V. L., Ignatovich V. F. Electron microscopy of surface structures of Rickettsia prowazeki stained with ruthenium red. Acta Virol. 1976 Oct;20(5):424–428. [PubMed] [Google Scholar]
  81. Public Health Weekly Reports for FEBRUARY 23, 1923. Public Health Rep. 1923 Feb 23;38(8):333–381. [PMC free article] [PubMed] [Google Scholar]
  82. Public Health Weekly Reports for OCTOBER 9, 1925. Public Health Rep. 1925 Oct 9;40(41):2159–2208. [PMC free article] [PubMed] [Google Scholar]
  83. Ramm L. E., Winkler H. H. Identification of cholesterol in the receptor site for rickettsiae on sheep erythrocyte membranes. Infect Immun. 1976 Jan;13(1):120–126. doi: 10.1128/iai.13.1.120-126.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Randall M. B., Walker D. H. Rocky Mountain spotted fever. Gastrointestinal and pancreatic lesions and rickettsial infection. Arch Pathol Lab Med. 1984 Dec;108(12):963–967. [PubMed] [Google Scholar]
  85. Rao A. K., Schapira M., Clements M. L., Niewiarowski S., Budzynski A. Z., Schmaier A. H., Harpel P. C., Blackwelder W. C., Scherrer J. R., Sobel E. A prospective study of platelets and plasma proteolytic systems during the early stages of Rocky Mountain spotted fever. N Engl J Med. 1988 Apr 21;318(16):1021–1028. doi: 10.1056/NEJM198804213181603. [DOI] [PubMed] [Google Scholar]
  86. Rees H. B., Jr, Weiss E. Glutamate catabolism of Rickettsia rickettsi and factors affecting retention of metabolic activity. J Bacteriol. 1968 Feb;95(2):389–396. doi: 10.1128/jb.95.2.389-396.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Robertson R. G., Wisseman C. L., Jr Tick-borne rickettsiae of the spotted fever group in West Pakistan. II. Serological classification of isolates from West Pakistan and Thailand: evidence for two new species. Am J Epidemiol. 1973 Jan;97(1):55–64. doi: 10.1093/oxfordjournals.aje.a121485. [DOI] [PubMed] [Google Scholar]
  88. Rollwagen F. M., Dasch G. A., Jerrells T. R. Mechanisms of immunity to rickettsial infection: characterization of a cytotoxic effector cell. J Immunol. 1986 Feb 15;136(4):1418–1421. [PubMed] [Google Scholar]
  89. Sacks H. S., Lyons R. W., Lahiri B. Adult respiratory distress syndrome in Rocky Mountain spotted fever. Am Rev Respir Dis. 1981 May;123(5):547–549. doi: 10.1164/arrd.1981.123.5.547. [DOI] [PubMed] [Google Scholar]
  90. Salgo M. P., Telzak E. E., Currie B., Perlman D. C., Litman N., Levi M., Nathenson G., Benach J. L., Al-Hafidh R., Casey J. A focus of Rocky Mountain spotted fever within New York City. N Engl J Med. 1988 May 26;318(21):1345–1348. doi: 10.1056/NEJM198805263182101. [DOI] [PubMed] [Google Scholar]
  91. Schramek S., Brezina R., Tarasevich I. V. Isolation of a lipopoly saccharide antigen from Rickettsia species. Acta Virol. 1976 Jun;20(3):270–270. [PubMed] [Google Scholar]
  92. Shepard C. C., Redus M. A., Tzianabos T., Warfield D. T. Recent experience with the complement fixation test in the laboratory diagnosis of rickettsial diseases in the United States. J Clin Microbiol. 1976 Sep;4(3):277–283. doi: 10.1128/jcm.4.3.277-283.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Shirai A., Dietel J. W., Osterman J. V. Indirect hemagglutination test for human antibody to typhus and spotted fever group rickettsiae. J Clin Microbiol. 1975 Nov;2(5):430–437. doi: 10.1128/jcm.2.5.430-437.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Silverman D. J., Santucci L. A. Potential for free radical-induced lipid peroxidation as a cause of endothelial cell injury in Rocky Mountain spotted fever. Infect Immun. 1988 Dec;56(12):3110–3115. doi: 10.1128/iai.56.12.3110-3115.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Silverman D. J., Wisseman C. L., Jr Comparative ultrastructural study on the cell envelopes of Rickettsia prowazekii, Rickettsia rickettsii, and Rickettsia tsutsugamushi. Infect Immun. 1978 Sep;21(3):1020–1023. doi: 10.1128/iai.21.3.1020-1023.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Silverman D. J., Wisseman C. L., Jr In vitro studies of rickettsia-host cell interactions: ultrastructural changes induced by Rickettsia rickettsii infection of chicken embryo fibroblasts. Infect Immun. 1979 Nov;26(2):714–727. doi: 10.1128/iai.26.2.714-727.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Silverman D. J., Wisseman C. L., Jr, Waddell A. D., Jones M. External layers of Rickettsia prowazekii and Rickettsia rickettsii: occurrence of a slime layer. Infect Immun. 1978 Oct;22(1):233–246. doi: 10.1128/iai.22.1.233-246.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Smith D. K., Winkler H. H. Characterization of a lysine-specific active transport system in Rickettsia prowazeki. J Bacteriol. 1977 Mar;129(3):1349–1355. doi: 10.1128/jb.129.3.1349-1355.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Taylor J. P., Istre G. R., McChesney T. C. The epidemiology of Rocky Mountain spotted fever in Arkansas, Oklahoma, and Texas, 1981 through 1985. Am J Epidemiol. 1988 Jun;127(6):1295–1301. doi: 10.1093/oxfordjournals.aje.a114922. [DOI] [PubMed] [Google Scholar]
  100. Tyeryar F. J., Jr, Weiss E., Millar D. B., Bozeman F. M., Ormsbee R. A. DNA base composition of rickettsiae. Science. 1973 Apr 27;180(4084):415–417. doi: 10.1126/science.180.4084.415. [DOI] [PubMed] [Google Scholar]
  101. Uchida T., Tashiro F., Funato T., Kitamura Y. Isolation of a spotted fever group Rickettsia from a patient with febrile exanthematous illness in Shikoku, Japan. Microbiol Immunol. 1986;30(12):1323–1326. doi: 10.1111/j.1348-0421.1986.tb03053.x. [DOI] [PubMed] [Google Scholar]
  102. Vianna N. J., Hinman A. R. Rocky Mountain spotted fever on Long Island. Epidemiologic and clinical aspects. Am J Med. 1971 Dec;51(6):725–730. doi: 10.1016/0002-9343(71)90300-7. [DOI] [PubMed] [Google Scholar]
  103. Walker D. H., Cain B. G. A method for specific diagnosis of Rocky Mountain spotted fever on fixed, paraffin-embedded tissue by immunofluorescence. J Infect Dis. 1978 Feb;137(2):206–209. doi: 10.1093/infdis/137.2.206. [DOI] [PubMed] [Google Scholar]
  104. Walker D. H., Cain B. G., Olmstead P. M. Laboratory diagnosis of Rocky Mountain spotted fever by immunofluorescent demonstration of Rickettsia in Cutaneous lesions. Am J Clin Pathol. 1978 Jun;69(6):619–623. doi: 10.1093/ajcp/69.6.619. [DOI] [PubMed] [Google Scholar]
  105. Walker D. H., Cain B. G. The rickettsial plaque. Evidence for direct cytopathic effect of Rickettsia rickettsii. Lab Invest. 1980 Oct;43(4):388–396. [PubMed] [Google Scholar]
  106. Walker D. H., Crawford C. G., Cain B. G. Rickettsial infection of the pulmonary microcirculation: the basis for interstitial pneumonitis in Rocky Mountain spotted fever. Hum Pathol. 1980 May;11(3):263–272. doi: 10.1016/s0046-8177(80)80008-6. [DOI] [PubMed] [Google Scholar]
  107. Walker D. H., Firth W. T., Ballard J. G., Hegarty B. C. Role of phospholipase-associated penetration mechanism in cell injury by Rickettsia rickettsii. Infect Immun. 1983 May;40(2):840–842. doi: 10.1128/iai.40.2.840-842.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Walker D. H., Firth W. T., Edgell C. J. Human endothelial cell culture plaques induced by Rickettsia rickettsii. Infect Immun. 1982 Jul;37(1):301–306. doi: 10.1128/iai.37.1.301-306.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Walker D. H., Firth W. T., Hegarty B. C. Injury restricted to cells infected with spotted fever group rickettsiae in parabiotic chambers. Acta Trop. 1984 Dec;41(4):307–312. [PubMed] [Google Scholar]
  110. Walker D. H., Hawkins H. K., Hudson P. Fulminant Rocky Mountain spotted fever. Its pathologic characteristics associated with glucose-6-phosphate dehydrogenase deficiency. Arch Pathol Lab Med. 1983 Mar;107(3):121–125. [PubMed] [Google Scholar]
  111. Walker D. H., Henderson F. W. Effect of immunosuppression on Rickettsia rickettsii infection in guinea pigs. Infect Immun. 1978 Apr;20(1):221–227. doi: 10.1128/iai.20.1.221-227.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Walker D. H., Henderson F. W., Hutchins G. M. Rocky Mountain spotted fever: mimicry of appendicitis or acute surgical abdomen? Am J Dis Child. 1986 Aug;140(8):742–744. doi: 10.1001/archpedi.1986.02140220024020. [DOI] [PubMed] [Google Scholar]
  113. Walker D. H., Lesesne H. R., Varma V. A., Thacker W. C. Rocky Mountain spotted fever mimicking acute cholecystitis. Arch Intern Med. 1985 Dec;145(12):2194–2196. [PubMed] [Google Scholar]
  114. Walker D. H., Mattern W. D. Acute renal failure in Rocky Mountain spotted fever. Arch Intern Med. 1979 Apr;139(4):443–448. [PubMed] [Google Scholar]
  115. Walker D. H., Mattern W. D. Rickettsial vasculitis. Am Heart J. 1980 Dec;100(6 Pt 1):896–906. doi: 10.1016/0002-8703(80)90072-1. [DOI] [PubMed] [Google Scholar]
  116. Walker D. H., Radisch D. L., Kirkman H. N. Haemolysis with rickettsiosis and glucose-6-phosphate dehydrogenase deficiency. Lancet. 1983 Jul 23;2(8343):217–217. doi: 10.1016/s0140-6736(83)90194-0. [DOI] [PubMed] [Google Scholar]
  117. Walker D. H., Tidwell R. R., Rector T. M., Geratz J. D. Effect of synthetic protease inhibitors of the amidine type on cell injury by Rickettsia rickettsii. Antimicrob Agents Chemother. 1984 May;25(5):582–585. doi: 10.1128/aac.25.5.582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Walker T. S. Rickettsial interactions with human endothelial cells in vitro: adherence and entry. Infect Immun. 1984 May;44(2):205–210. doi: 10.1128/iai.44.2.205-210.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Walker T. S., Winkler H. H. Penetration of cultured mouse fibroblasts (L cells) by Rickettsia prowazeki. Infect Immun. 1978 Oct;22(1):200–208. doi: 10.1128/iai.22.1.200-208.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Westerman E. L. Rocky Mountain spotless fever: a dilemma for the clinician. Arch Intern Med. 1982 Jun;142(6):1106–1107. [PubMed] [Google Scholar]
  121. Wilfert C. M., MacCormack J. N., Kleeman K., Philip R. N., Austin E., Dickinson V., Turner L. Epidemiology of Rocky Mountain spotted fever as determined by active surveillance. J Infect Dis. 1984 Oct;150(4):469–479. doi: 10.1093/infdis/150.4.469. [DOI] [PubMed] [Google Scholar]
  122. Williams J. C., Walker D. H., Peacock M. G., Stewart S. T. Humoral immune response to Rocky Mountain spotted fever in experimentally infected guinea pigs: immunoprecipitation of lactoperoxidase 125I-labeled proteins and detection of soluble antigens of Rickettsia rickettsii. Infect Immun. 1986 Apr;52(1):120–127. doi: 10.1128/iai.52.1.120-127.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  123. Winkler H. H., Daugherty R. M. Phospholipase A activity associated with the growth of Rickettsia prowazekii in L929 cells. Infect Immun. 1989 Jan;57(1):36–40. doi: 10.1128/iai.57.1.36-40.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Winkler H. H., Daugherty R. M. Proline transport and metabolism in Rickettsia prowazekii. J Bacteriol. 1984 May;158(2):460–463. doi: 10.1128/jb.158.2.460-463.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  125. Winkler H. H., Miller E. T. Phospholipase A activity in the hemolysis of sheep and human erythrocytes by Rickettsia prowazeki. Infect Immun. 1980 Aug;29(2):316–321. doi: 10.1128/iai.29.2.316-321.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  126. Winkler H. H. Rickettsial permeability. An ADP-ATP transport system. J Biol Chem. 1976 Jan 25;251(2):389–396. [PubMed] [Google Scholar]
  127. Wisseman C. L., Jr, Edlinger E. A., Waddell A. D., Jones M. R. Infection cycle of Rickettsia rickettsii in chicken embryo and L-929 cells in culture. Infect Immun. 1976 Oct;14(4):1052–1064. doi: 10.1128/iai.14.4.1052-1064.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  128. Wisseman C. L., Jr, Waddell A. D. In vitro studies on rickettsia-host cell interactions: intracellular growth cycle of virulent and attenuated Rickettsia prowazeki in chicken embryo cells in slide chamber cultures. Infect Immun. 1975 Jun;11(6):1391–1404. doi: 10.1128/iai.11.6.1391-1401.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  129. Wisseman C. L., Jr, Waddell A. Interferonlike factors from antigen- and mitogen-stimulated human leukocytes with antirickettsial and cytolytic actions on Rickettsia prowazekii. Infected human endothelial cells, fibroblasts, and macrophages. J Exp Med. 1983 Jun 1;157(6):1780–1793. doi: 10.1084/jem.157.6.1780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. Woodward T. E., Pedersen C. E., Jr, Oster C. N., Bagley L. R., Romberger J., Snyder M. J. Prompt confirmation of Rocky Mountain spotted fever: identification of rickettsiae in skin tissues. J Infect Dis. 1976 Sep;134(3):297–301. doi: 10.1093/infdis/134.3.297. [DOI] [PubMed] [Google Scholar]
  131. Yamada T., Harber P., Pettit G. W., Wing D. A., Oster C. N. Activation of the kallikrein-kinin system in Rocky Mountain spotted fever. Ann Intern Med. 1978 Jun;88(6):764–768. doi: 10.7326/0003-4819-88-6-764. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES